GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com

Apr
23th

Supplier : GenTarget

Country : | Number of Products : 3151 | View all products

About this Supplier: website

h AR inducible lentiviral particles
h AR inducible lentiviral particles , premade lentiviral particles
h ENO1 inducible lentiviral particles
h ENO1 inducible lentiviral particles , premade lentiviral particles
h ENO1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: ENO1 (alternative name: ENO1L1, MPB1, NNE, PPH). The sub-cloned codon sequence is
h HIF1A inducible lentiviral particles
h HIF1A inducible lentiviral particles , premade lentiviral particles
h HIF1A inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: HIF1A (alternative name: HIF1; MOP1; PASD8; HIF-1A; bHLHe78; HIF-1alpha; HIF1-AL
h KLF1 inducible lentiviral particles
h KLF1 inducible lentiviral particles , premade lentiviral particles
h KLF1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: KLF1 (alternative name: EKLF, HBFQTL6, INLU). The sub-cloned codon sequence is id
h MSX2 inducible lentiviral particles
h MSX2 inducible lentiviral particles , premade lentiviral particles
h MSX2 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: MSX2 (alternative name: CRS2, FPP, HOX8, MSH, PFM, PFM1). The sub-cloned codon se
h OCT4 (EF1a) (Puro) Lentiviral particles
h OCT4 (EF1a) (Puro) Lentiviral particles, premade lentiviral particles
h OCT4 (EF1a) (RP) Lentiviral particles
h OCT4 (EF1a) (RP) Lentiviral particles, premade lentiviral particles
h OCT4 (EF1a) Lentiviral particles: Pre-made serum-free lentiviral particles constitutively expressing human Oct3_4 gene under EF1a promoter.
h OCT4 (EF1a) Lentiviral particles; premade lentiviral particles
h OCT4 (Neo) inducible particles
h OCT4 (Neo) inducible particles, premade lentiviral particles
h OCT4 (Neo) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human Oct3_4 gene. A Neomycin marker was expressed under RSV promoter.
h OCT4 (Neo) inducible particles; premade lentiviral particles
h OCT4 (RFP-Bsd) inducible particles
h OCT4 (RFP-Bsd) inducible particles, premade lentiviral particles
h OCT4 (RFP-Bsd) inducible particles: Pre-made tet-inducible, serum-free lentiviral particles expressing human Oct3_4 gene. A Blasticidin-RFP fusion marker was expressed under RSV promoter.
h OCT4 (RFP-Bsd) inducible particles; premade lentiviral particles
h TRPV1 inducible lentiviral particles
h TRPV1 inducible lentiviral particles , premade lentiviral particles
h TRPV1 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: TRPV1 (alternative name: VR1, OTRPC1). The sub-cloned codon sequence is identica
h ZDHHC17 inducible lentiviral particles
h ZDHHC17 inducible lentiviral particles , premade lentiviral particles
h ZDHHC17 inducible lentiviral particles : Pre-made optional inducible lentiviral particles for expressing human target: ZDHHC17 (alternative name: HSPC294, HIP14, HIP3, HYPH, DHHC-17). The sub-clone
Luciferase (firefly)- 2A-GFP (RFP-Bsd), in vivo ready
Luciferase (firefly)- 2A-GFP (RFP-Bsd), in vivo ready, premade lentiviral particles
Luciferase (firefly)- 2A-GFP (RFP-Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under optinal inducible CMV promoter. And a RFP-Blasticidin
Luciferase (firefly)- 2A-GFP (RFP-Puro), in vivo ready
Luciferase (firefly)- 2A-GFP (RFP-Puro), in vivo ready, premade lentiviral particles
Luciferase (firefly)- 2A-GFP (RFP-Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under optinal inducible CMV promoter. And a RFP-Puromycin f
293-CFP, stable cell lines
293-CFP: Stable cell line expressing CFP with Blasticidin resistance
293-CFP; stable cell lines
293-GFP, stable cell lines
293-GFP: GFP stable cell line with Blasticidin resistance
293-GFP; stable cell lines
293-RFP stable cells, stable cell lines
293-RFP stable cells: Humanized Red fluorescent protein (RFP) stable cell line with Blasticidin resistance
293-RFP stable cells; stable cell lines
293-YFP, stable cell lines
293-YFP: Stable cell line expressing YFP with Blasticidin resistance
293-YFP; stable cell lines
293T lentivirus packing cells, stable cell lines
293T lentivirus packing cells: Lentiviral Packaging Cell Line. 293HEK cells stably expressing SV40 larget T-antigen, for producing high-titer lentivirus when transfected with lentiviral vectors.
293T lentivirus packing cells; stable cell lines
CAG-Luciferase (firefly) (Bsd)
CAG-Luciferase (firefly) (Bsd) , premade lentiviral particles
CAG-Luciferase (firefly) (Bsd), in vivo ready
CAG-Luciferase (firefly) (Bsd), in vivo ready , premade lentiviral particles
CAG-Luciferase (firefly) (GFP-Puro)
CAG-Luciferase (firefly) (GFP-Puro) , premade lentiviral particles
CAG-Luciferase (firefly) (GFP-Puro), in vivo ready
CAG-Luciferase (firefly) (GFP-Puro), in vivo ready , premade lentiviral particles
CAG-Luciferase (firefly) (Neo)
CAG-Luciferase (firefly) (Neo) , premade lentiviral particles
CAG-Luciferase (firefly) (Neo), in vivo ready
CAG-Luciferase (firefly) (Neo), in vivo ready , premade lentiviral particles
CAG-Luciferase (firefly) (Puro)
CAG-Luciferase (firefly) (Puro) , premade lentiviral particles
CAG-Luciferase (firefly) (Puro), in vivo ready
CAG-Luciferase (firefly) (Puro), in vivo ready , premade lentiviral particles
CAG-Luciferase (firefly) (RFP-Bsd)
CAG-Luciferase (firefly) (RFP-Bsd) , premade lentiviral particles
CAG-Luciferase (firefly) (RFP-Bsd), in vivo ready
CAG-Luciferase (firefly) (RFP-Bsd), in vivo ready , premade lentiviral particles
CAG-Luciferase (firefly) (RFP-Puro)
CAG-Luciferase (firefly) (RFP-Puro) , premade lentiviral particles
CAG-Luciferase (firefly) (RFP-Puro), in vivo ready
CAG-Luciferase (firefly) (RFP-Puro), in vivo ready , premade lentiviral particles
CFP (Bsd) lentiviral particles
CFP (Bsd) lentiviral particles
CFP (Bsd) lentiviral particles, in vivo ready
CFP (Bsd) lentiviral particles, in vivo ready
CFP (CAG)-Bsd lentiviral particles
CFP (CAG)-Bsd lentiviral particles, in vivo ready
CFP (CAG)-Neo lentiviral particles
CFP (CAG)-Neo lentiviral particles, in vivo ready
CFP (CAG)-Neo lentiviral particles, in vivo ready, premade lentiviral particles
CFP (CAG)-Neo lentiviral particles, premade lentiviral particles
CFP (CAG)-Puro lentiviral particles
CFP (CAG)-Puro lentiviral particles, in vivo ready
CFP (CAG)-Puro lentiviral particles, premade lentiviral particles
CFP (EF1a)-Bsd lentiviral particles
CFP (EF1a)-Bsd lentiviral particles, in vivo ready
CFP (EF1a)-Bsd lentiviral particles, in vivo ready, premade lentiviral particles
CFP (EF1a)-Bsd lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP under EF1a promoter with Blasticidin selection marker, provided in PBS solution.
CFP (EF1a)-Bsd lentiviral particles, in vivo ready; premade lentiviral particles
CFP (EF1a)-Neo lentiviral particles
CFP (EF1a)-Neo lentiviral particles, in vivo ready
CFP (EF1a)-Neo lentiviral particles, in vivo ready, premade lentiviral particles
CFP (EF1a)-Neo lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP under EF1a promoter with Neomycin selection marker, provided in PBS solution.
CFP (EF1a)-Neo lentiviral particles, in vivo ready; premade lentiviral particles
CFP (EF1a)-Puro lentiviral particles
CFP (EF1a)-Puro lentiviral particles, in vivo ready
CFP (EF1a)-Puro lentiviral particles, in vivo ready, premade lentiviral particles
CFP (EF1a)-Puro lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP under EF1a promoter with Puromycin selection marker, provided in PBS solution.
CFP (EF1a)-Puro lentiviral particles, in vivo ready; premade lentiviral particles
CFP (EF1a)-RB lentiviral particles
CFP (EF1a)-RB lentiviral particles
CFP (Neo) lentiviral particles
CFP (Neo) lentiviral particles, in vivo ready
CFP (Neo) lentiviral particles, in vivo ready, premade lentiviral particles
CFP (Neo) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP with Neomycin antibiotic marker, provided in PBS solution as in vivo ready.
CFP (Neo) lentiviral particles, in vivo ready; premade lentiviral particles
CFP (Neo) lentiviral particles, premade lentiviral particles
CFP (Neo) lentiviral particles: Pre-made lentiviral particles expressing CFP with Neomycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene.
CFP (Neo) lentiviral particles; premade lentiviral particles
CFP (puro) lentiviral particles
CFP (Puro) lentiviral particles, in vivo ready
CFP (Puro) lentiviral particles, in vivo ready, premade lentiviral particles
CFP (Puro) lentiviral particles, in vivo ready: Pre-made lentiviral particles expressing CFP with Puromycin antibiotic marker, concentrated particles provided in PBS solution.
CFP (Puro) lentiviral particles, in vivo ready; premade lentiviral particles
CFP (puro) lentiviral particles, premade lentiviral particles
CFP (puro) lentiviral particles: Pre-made lentiviral particles expressing CFP with Puromycin antibiotic marker, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene.
CFP (puro) lentiviral particles; premade lentiviral particles
CFP expression Adenovirus
CFP expression Adenovirus, in vivo ready
CFP-Actin fusion Lentiviral particles
CFP-Actin fusion Lentiviral particles, premade lentiviral particles
CFP-Actin fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Actin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly
CFP-Actin fusion Lentiviral particles; premade lentiviral particles
CFP-Annexin5 fusion Lentiviral particles
CFP-Annexin5 fusion Lentiviral particles, premade lentiviral particles
CFP-Annexin5 fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Annexin 5) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml
CFP-Annexin5 fusion Lentiviral particles; premade lentiviral particles
CFP-CLCN2 fusion lentiviral particles
CFP-CLCN2 fusion lentiviral particles, premade lentiviral particles
CFP-CSF1 fusion lentiviral particles
CFP-CSF1 fusion lentiviral particles, premade lentiviral particles
CFP-Histone 2B fusion lentiviral particles
CFP-Histone 2B fusion lentiviral particles, premade lentiviral particles
CFP-Histone 2B fusion lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Histone 2B) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_
CFP-Histone 2B fusion lentiviral particles; premade lentiviral particles
CFP-hP53 fusion Lentiviral particles
CFP-hP53 fusion Lentiviral particles, premade lentiviral particles
CFP-hP53 fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human P53) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybre
CFP-hP53 fusion Lentiviral particles; premade lentiviral particles
CFP-KCNN4 fusion lentiviral particles
CFP-KCNN4 fusion lentiviral particles, premade lentiviral particles
CFP-RFP fusion control lentiviral particles
CFP-RFP fusion control lentiviral particles, premade lentiviral particles
CFP-RFP fusion control lentiviral particles: Pre-made lentiviral particles expressing CFP-RFP fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren
CFP-RFP fusion control lentiviral particles; premade lentiviral particles
CFP-TAT fusion Lentiviral particles
CFP-TAT fusion Lentiviral particles, premade lentiviral particles
CFP-TAT fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-HIV-1 Tat) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybren
CFP-TAT fusion Lentiviral particles; premade lentiviral particles
CFP-TRPC3 fusion lentiviral particles
CFP-TRPC3 fusion lentiviral particles, premade lentiviral particles
CFP-TRPV1 fusion lentiviral particles
CFP-TRPV1 fusion lentiviral particles, premade lentiviral particles
CFP-Zyxin fusion Lentiviral particles
CFP-Zyxin fusion Lentiviral particles, premade lentiviral particles
CFP-Zyxin fusion Lentiviral particles: Pre-made lentiviral particles expressing (CFP-human Zyxin) fusion contruct under suCMV promoter, provided in DMEM medium with 10 percent FBS and 60ug_ml of poly
CFP-Zyxin fusion Lentiviral particles; premade lentiviral particles
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles
Chained human iPS (MKOS) (RFP-Puro) lentiviral particles, premade lentiviral particles
Chained human iPS (OKSM) inducible lentiviral particles: prmade lentivirus from single vector for iPS cell generation, expressing four human iPS factor, c-Myc, Klf4, Oct4 and Sox2 under a Tetracycline
Chained human iPS (OKSM) inducible lentiviral particles; premade lentiviral particles
Chained mouse iPS (MKOS) (RFP-Puro) lentiviral particles
Chained mouse iPS (MKOS) (RFP-Puro) lentiviral particles
Chained mouse iPS (OKSM) inducible lentiviral particles: prmade lentivirus from single vector for iPS cell generation, expressing four mouse iPS factor, c-Myc, Klf4, Oct4 and Sox2 under a Tetracycline
Chained mouse iPS (OKSM) inducible lentiviral particles; premade lentiviral particles
CMV Control lentiviral particles (Bsd)
CMV Control lentiviral particles (Bsd) in PBS
CMV Control lentiviral particles (Bsd), premade lentiviral particles
CMV Control lentiviral particles (Bsd): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any
CMV Control lentiviral particles (GFP-Bsd)
CMV Control lentiviral particles (GFP-Bsd) in PBS
CMV Control lentiviral particles (GFP-Bsd), premade lentiviral particles
CMV Control lentiviral particles (GFP-Bsd): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of
CMV Control lentiviral particles (GFP-Puro)
CMV Control lentiviral particles (GFP-Puro) in PBS
CMV Control lentiviral particles (GFP-Puro), premade lentiviral particles
CMV Control lentiviral particles (GFP-Puro): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of
CMV Control lentiviral particles (Neo)
CMV Control lentiviral particles (Neo) in PBS
CMV Control lentiviral particles (Neo), premade lentiviral particles
CMV Control lentiviral particles (Neo): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any
CMV Control lentiviral particles (Puro)
CMV Control lentiviral particles (Puro) in PBS
CMV Control lentiviral particles (Puro), premade lentiviral particles
CMV Control lentiviral particles (Puro): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any
CMV Control lentiviral particles (RFP-Bsd)
CMV Control lentiviral particles (RFP-Bsd) in PBS
CMV Control lentiviral particles (RFP-Bsd), premade lentiviral particles
CMV Control lentiviral particles (RFP-Bsd): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of
CMV Control lentiviral particles (RFP-Puro)
CMV Control lentiviral particles (RFP-Puro) in PBS
CMV Control lentiviral particles (RFP-Puro), premade lentiviral particles
CMV Control lentiviral particles (RFP-Puro): Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of
CMV-Null control Adenovirus
CMV-Null control Adenovirus, in vivo ready
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles
CMV-TetR (Bsd) Lentiviral particles, premade lentiviral particles
CMV-TetR (Bsd) Lentiviral particles: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Hygromycin antibiotic marker.
CMV-TetR (Hygro) Lentiviral particles
CMV-TetR (Hygro) Lentiviral particles
CMV-TetR (Neo) Lentiviral particles
CMV-TetR (Neo) Lentiviral particles
CMV-TetR (Puro) Lentiviral particles
CMV-TetR (Puro) Lentiviral particles
CMV-TetR (RFP-Bsd) Lentiviral particles
CMV-TetR (RFP-Bsd) Lentiviral particles
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Bsd)
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Bsd) , premade lentiviral particles
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Bsd) : CRE reporter cell line (Bsd): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Blasticidin antibiotic marker
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro)
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) , premade lentiviral particles
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) : CRE reporter cell line (Puro): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Puromycin antibiotic marker
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo)
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo) , premade lentiviral particles
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo) : CRE reporter cell line (Neo): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Neomycin antibiotic marker
CRE (Bsd), CAG lentivirus in PBS
CRE (Bsd), CAG lentivirus in PBS, premade lentiviral particles
CRE (Bsd), CAG lentivirus
CRE (Bsd), CAG lentivirus, premade lentiviral particles
CRE (Bsd), CMV lentivirus
CRE (Bsd), CMV lentivirus in PBS
CRE (Bsd), CMV lentivirus, premade lentiviral particles
CRE (Bsd), CMV lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker, provided in DMEM medium with 10 percent FBS.
CRE (Bsd), EF1a lentivirus
CRE (Bsd), EF1a lentivirus in PBS
CRE (Bsd), EF1a lentivirus, premade lentiviral particles
CRE (Bsd), EF1a lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker, provided in DMEM medium with 10 percent FBS.
CRE (GFP-Puro), CAG lentivirus
CRE (GFP-Puro), CAG lentivirus in PBS
CRE (GFP-Puro), CAG lentivirus in PBS, premade lentiviral particles
CRE (GFP-Puro), CAG lentivirus, premade lentiviral particles
CRE (Neo), CAG lentivirus, in PBS
CRE (Neo), CAG lentivirus, in PBS, premade lentiviral particles
CRE (Neo), CAG lentivirus
CRE (Neo), CAG lentivirus, premade lentiviral particles
CRE (Neo), CMV lentivirus
CRE (Neo), CMV lentivirus, in PBS
CRE (Neo), CMV lentivirus, premade lentiviral particles
CRE (Neo), CMV lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker, provided in DMEM medium with 10 percent FBS.
CRE (Neo), EF1a lentivirus
CRE (Neo), EF1a lentivirus, in PBS
CRE (Neo), EF1a lentivirus, premade lentiviral particles
CRE (Neo), EF1a lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker, provided in DMEM medium with 10 percent FBS.
CRE (Puro), CAG lentivirus in PBS
CRE (Puro), CAG lentivirus in PBS , premade lentiviral particles
CRE (Puro), CAG lentivirus
CRE (Puro), CAG lentivirus, premade lentiviral particles
CRE (Puro), CMV lentivirus
CRE (Puro), CMV lentivirus in PBS
CRE (Puro), CMV lentivirus, premade lentiviral particles
CRE (Puro), CMV lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Puromycin marker, provided in DMEM medium with 10 percent FBS.
CRE (Puro), EF1a lentivirus
CRE (Puro), EF1a lentivirus in PBS
CRE (Puro), EF1a lentivirus, premade lentiviral particles
CRE (Puro), EF1a lentivirus: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Puromycin marker, provided in DMEM medium with 10 percent FBS.
CRE (RFP-Bsd), CAG lentivirus
CRE (RFP-Bsd), CAG lentivirus in PBS
CRE (RFP-Bsd), CAG lentivirus in PBS, premade lentiviral particles
CRE (RFP-Bsd), CAG lentivirus, premade lentiviral particles
CRE (RFP-Puro), CAG lentivirus
CRE (RFP-Puro), CAG lentivirus in PBS
CRE (RFP-Puro), CAG lentivirus in PBS, premade lentiviral particles
CRE (RFP-Puro), CAG lentivirus, premade lentiviral particles
CRE stable cells with GFP-Puromycin dual marker
CRE stable cells with GFP-Puromycin dual marker, stable cell lines
CRE stable cells with GFP-Puromycin dual marker: CRE recombinase stable cell line with puromycin resistance and GFP fluorescent marker.
CRE stable cells with Puromycin marker
CRE stable cells with Puromycin marker
CRE stable cells with Puromycin marker
CRE stable cells with Puromycin marker, stable cell lines
CRE stable cells with Puromycin marker, stable cell lines
CRE stable cells with Puromycin marker, stable cell lines
CRE stable cells with Puromycin marker: CRE recombinase stable cell line with Blasticidin resistance
CRE stable cells with Puromycin marker: CRE recombinase stable cell line with Neomycin resistance
CRE stable cells with Puromycin marker: CRE recombinase stable cell line with Puromycin resistance
CRE stable cells with RFP-blasticidin dual marker
CRE stable cells with RFP-blasticidin dual marker, stable cell lines
CRE stable cells with RFP-blasticidin dual marker: CRE recombinase stable cell line with Blasticidin resistance and RFP fluorescent marker.
CRE stable cells with RFP-Puromycin dual marker
CRE stable cells with RFP-Puromycin dual marker, stable cell lines
CRE stable cells with RFP-Puromycin dual marker: CRE recombinase stable cell line with puromycin resistance and RFP fluorescent marker.
CRE stable cells; stable cell lines
CRE-2A-GFP (Bsd), CMV lentivirus
CRE-2A-GFP (Bsd), CMV lentivirus in PBS
CRE-2A-GFP (Bsd), CMV lentivirus, premade lentiviral particles
CRE-2A-GFP (Bsd), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Blasticidin mar
CRE-2A-GFP (Bsd), EF1a lentivirus
CRE-2A-GFP (Bsd), EF1a lentivirus in PBS
CRE-2A-GFP (Bsd), EF1a lentivirus, premade lentiviral particles
CRE-2A-GFP (Bsd), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A B
CRE-2A-GFP (Neo), CMV lentivirus
CRE-2A-GFP (Neo), CMV lentivirus in PBS
CRE-2A-GFP (Neo), CMV lentivirus, premade lentiviral particles
CRE-2A-GFP (Neo), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Neomycin marker
CRE-2A-GFP (Neo), EF1a lentivirus
CRE-2A-GFP (Neo), EF1a lentivirus in PBS
CRE-2A-GFP (Neo), EF1a lentivirus, premade lentiviral particles
CRE-2A-GFP (Neo), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A N
CRE-2A-GFP (Puro), CMV lentivirus
CRE-2A-GFP (Puro), CMV lentivirus in PBS
CRE-2A-GFP (Puro), CMV lentivirus, premade lentiviral particles
CRE-2A-GFP (Puro), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Puromycin mark
CRE-2A-GFP (Puro), EF1a lentivirus
CRE-2A-GFP (Puro), EF1a lentivirus in PBS
CRE-2A-GFP (Puro), EF1a lentivirus, premade lentiviral particles
CRE-2A-GFP (Puro), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A
CRE-2A-RFP (Bsd), CMV lentivirus
CRE-2A-RFP (Bsd), CMV lentivirus in PBS
CRE-2A-RFP (Bsd), CMV lentivirus, premade lentiviral particles
CRE-2A-RFP (Bsd), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Blasticidin mar
CRE-2A-RFP (Bsd), EF1a lentivirus
CRE-2A-RFP (Bsd), EF1a lentivirus in PBS
CRE-2A-RFP (Bsd), EF1a lentivirus, premade lentiviral particles
CRE-2A-RFP (Bsd), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Bl
CRE-2A-RFP (Neo), CMV lentivirus
CRE-2A-RFP (Neo), CMV lentivirus in PBS
CRE-2A-RFP (Neo), CMV lentivirus, premade lentiviral particles
CRE-2A-RFP (Neo), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Neomycin marker
CRE-2A-RFP (Neo), EF1a lentivirus
CRE-2A-RFP (Neo), EF1a lentivirus in PBS
CRE-2A-RFP (Neo), EF1a lentivirus, premade lentiviral particles
CRE-2A-RFP (Neo), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A N
CRE-2A-RFP (Puro), CMV lentivirus
CRE-2A-RFP (Puro), CMV lentivirus in PBS
CRE-2A-RFP (Puro), CMV lentivirus, premade lentiviral particles
CRE-2A-RFP (Puro), CMV lentivirus: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Puromycin mark
CRE-2A-RFP (Puro), EF1a lentivirus
CRE-2A-RFP (Puro), EF1a lentivirus in PBS
CRE-2A-RFP (Puro), EF1a lentivirus, premade lentiviral particles
CRE-2A-RFP (Puro), EF1a lentivirus: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A
Cyto-CFP, LocLight lentiviral particles
Cyto-CFP, LocLight lentiviral particles , premade lentiviral particles
Cyto-CFP, LocLight lentiviral particles : Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. CFP fluorescent si
Cyto-CFP, LocLight lentiviral particles ; premade lentiviral particles
Cyto-GFP, LocLight lentiviral particles
Cyto-GFP, LocLight lentiviral particles , premade lentiviral particles
Cyto-GFP, LocLight lentiviral particles : Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. GFP fluorescent si
Cyto-GFP, LocLight lentiviral particles ; premade lentiviral particles
Cyto-RFP, LocLight lentiviral particles
Cyto-RFP, LocLight lentiviral particles , premade lentiviral particles
Cyto-RFP, LocLight lentiviral particles : Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10 percent FBS and 60ug_ml of polybrene. RFP fluorescent si
Cyto-RFP, LocLight lentiviral particles ; premade lentiviral particles
EcoTM Expression RichMedium, protein expression
EcoTM Expression RichMedium: auto induction medium for E Coli T7 promoter based expression system
EcoTM Expression RichMedium; protein expression
EF1a Control lentiviral particles (Bsd)
EF1a Control lentiviral particles (Bsd) in PBS
EF1a Control lentiviral particles (Bsd), premade lentiviral particles
EF1a Control lentiviral particles (Bsd): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of an
EF1a Control lentiviral particles (GFP-Bsd)
EF1a Control lentiviral particles (GFP-Bsd) in PBS
EF1a Control lentiviral particles (GFP-Bsd), premade lentiviral particles
EF1a Control lentiviral particles (GFP-Bsd): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity o
EF1a Control lentiviral particles (GFP-Puro)
EF1a Control lentiviral particles (GFP-Puro) in PBS
EF1a Control lentiviral particles (GFP-Puro), premade lentiviral particles
EF1a Control lentiviral particles (GFP-Puro): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity
EF1a Control lentiviral particles (Neo)
EF1a Control lentiviral particles (Neo) in PBS
EF1a Control lentiviral particles (Neo), premade lentiviral particles
EF1a Control lentiviral particles (Neo): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of an
EF1a Control lentiviral particles (Puro)
EF1a Control lentiviral particles (Puro) in PBS
EF1a Control lentiviral particles (Puro), premade lentiviral particles
EF1a Control lentiviral particles (Puro): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of a
EF1a Control lentiviral particles (RFP-Bsd)
EF1a Control lentiviral particles (RFP-Bsd) in PBS
EF1a Control lentiviral particles (RFP-Bsd), premade lentiviral particles
EF1a Control lentiviral particles (RFP-Bsd): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity o
EF1a Control lentiviral particles (RFP-Puro)
EF1a Control lentiviral particles (RFP-Puro) in PBS
EF1a Control lentiviral particles (RFP-Puro), premade lentiviral particles
EF1a Control lentiviral particles (RFP-Puro): Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity
EF1a-Luc (firefly)- 2A-GFP (RFP-Bsd)
EF1a-Luc (firefly)- 2A-GFP (RFP-Bsd) , premade lentiviral particles
EF1a-Luc (firefly)- 2A-GFP (RFP-Bsd) : Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Blasticidin fusion dual marker is
EF1a-Luc (firefly)- 2A-GFP (RFP-Bsd), in vivo ready
EF1a-Luc (firefly)- 2A-GFP (RFP-Bsd), in vivo ready, premade lentiviral particles
EF1a-Luc (firefly)- 2A-GFP (RFP-Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Blasticidin fusion d
EF1a-Luc (firefly)- 2A-GFP (RFP-Puro)
EF1a-Luc (firefly)- 2A-GFP (RFP-Puro) , premade lentiviral particles
EF1a-Luc (firefly)- 2A-GFP (RFP-Puro) : Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Puromycin fusion dual marker is e
EF1a-Luc (firefly)- 2A-GFP (RFP-Puro), in vivo ready
EF1a-Luc (firefly)- 2A-GFP (RFP-Puro), in vivo ready, premade lentiviral particles
EF1a-Luc (firefly)- 2A-GFP (RFP-Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP under an enhanced EF1a promoter. And a RFP-Puromycin fusion du
EF1a-Luciferase (firefly) (Bsd)
EF1a-Luciferase (firefly) (Bsd), premade lentiviral particles
EF1a-Luciferase (firefly) (Bsd): Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Blastidicin selection marker, provided in DMEM medium with 10 percent FBS and 60u
EF1a-Luciferase (firefly) (Bsd); premade lentiviral particles
EF1a-Luciferase (firefly) (Neo)
EF1a-Luciferase (firefly) (Neo), premade lentiviral particles
EF1a-Luciferase (firefly) (Neo): Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Neomycin selection marker, provided in DMEM medium with 10 percent FBS and 60ug_m
EF1a-Luciferase (firefly) (Neo); premade lentiviral particles
EF1a-Luciferase (firefly) (Puro)
EF1a-Luciferase (firefly) (Puro), premade lentiviral particles
EF1a-Luciferase (firefly) (Puro): Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Puromycin selection marker, provided in DMEM medium with 10 percent FBS and 60ug
EF1a-Luciferase (firefly) (Puro); premade lentiviral particles
EF1a-Luciferase (firefly), (Bsd), in vivo ready
EF1a-Luciferase (firefly), (Bsd), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly), (Bsd), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Blastidicin selection marker, provided in PBS solution.
EF1a-Luciferase (firefly), (Bsd), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly), (Neo), in vivo ready
EF1a-Luciferase (firefly), (Neo), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly), (Neo), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Neomycin selection marker, provided in PBS solution.
EF1a-Luciferase (firefly), (Neo), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly), (Puro), in vivo ready
EF1a-Luciferase (firefly), (Puro), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly), (Puro), in vivo ready: Pre-made lentiviral particles expressing firefly luciferase under EF1a promoter with Puromycin selection marker, provided in PBS solution.
EF1a-Luciferase (firefly), (Puro), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Bsd)
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selec
EF1a-Luciferase (firefly)-2A-GFP (Bsd), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Bsd), premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Bsd): Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selection marker und
EF1a-Luciferase (firefly)-2A-GFP (Bsd); premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Neo)
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selec
EF1a-Luciferase (firefly)-2A-GFP (Neo), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Neo), premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Neo): Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Neomycin selection marker und
EF1a-Luciferase (firefly)-2A-GFP (Neo); premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Puro)
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Puromycin sel
EF1a-Luciferase (firefly)-2A-GFP (Puro), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Puro), premade lentiviral particles
EF1a-Luciferase (firefly)-2A-GFP (Puro): Pre-made lentiviral particles bicistronically expressing firefly luciferase and GFP fluorescent protein under EF1a promoter, with Puromycin selection marker u
EF1a-Luciferase (firefly)-2A-GFP (Puro); premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Bsd)
EF1a-Luciferase (firefly)-2A-RFP (Bsd) , premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Bsd) : Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selection marker un
EF1a-Luciferase (firefly)-2A-RFP (Bsd) ; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selec
EF1a-Luciferase (firefly)-2A-RFP (Bsd), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Neo)
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selec
EF1a-Luciferase (firefly)-2A-RFP (Neo), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Neo), premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Neo): Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Neomycin selection marker und
EF1a-Luciferase (firefly)-2A-RFP (Neo); premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Puro)
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready, premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready: Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Puromycin sel
EF1a-Luciferase (firefly)-2A-RFP (Puro), in vivo ready; premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Puro), premade lentiviral particles
EF1a-Luciferase (firefly)-2A-RFP (Puro): Pre-made lentiviral particles bicistronically expressing firefly luciferase and RFP fluorescent protein under EF1a promoter, with Puromycin selection marker u
EF1a-Luciferase (firefly)-2A-RFP (Puro); premade lentiviral particles
EF1a-TetR (Bsd) Lentiviral particles
EF1a-TetR (Bsd) Lentiviral particles
EF1a-TetR (Bsd) Lentiviral particles
EF1a-TetR (GFP-Bsd) Lentiviral particles
EF1a-TetR (GFP-Bsd) Lentiviral particles
EF1a-TetR (GFP-Bsd) Lentiviral particles
EF1a-TetR (GFP-Bsd) Lentiviral particles
EF1a-TetR (Neo) Lentiviral particles
EF1a-TetR (Neo) Lentiviral particles
EF1a-TetR (Neo) Lentiviral particles
EF1a-TetR (Puro) Lentiviral particles
EF1a-TetR (Puro) Lentiviral particles
EF1a-TetR (Puro) Lentiviral particles
EF1a-TetR (RFP-Bsd) Lentiviral particles
EF1a-TetR (RFP-Bsd) Lentiviral particles
EF1a-TetR (RFP-Bsd) Lentiviral particles
EF1a-TetR (RFP-Bsd) Lentiviral particles
EF1a-TetR (RFP-Puro) Lentiviral particles
EF1a-TetR (RFP-Puro) Lentiviral particles
EF1a-TetR (RFP-Puro) Lentiviral particles
EF1a-TetR (RFP-Puro) Lentiviral particles
Endosomes-GFP, LocLight lentiviral particles
 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur